Literature DB >> 6626141

Postnatal changes in canine erythrocyte pyruvate kinase isozymes.

P A Mueggler, S Carpenter, J A Black.   

Abstract

The isozyme pattern of pyruvate kinase in canine erythrocytes changes following birth. These changes have been followed by electrophoretic, immunologic, and kinetic measurements of the isozymes. At birth, a mixture of isozymes is present consisting of the M2 isozyme and hybrid molecules containing M2 and R subunits. With increasing animal age, the content of M2 subunits decreases and the content of R subunits increases. At 6 months of age, the isozyme pattern is indistinguishable from that of adult erythrocytes which contain only the R tetramer. We conclude that there is a switch in erythrocyte pyruvate kinase gene expression during the first 6 months of postnatural life. The existence of hybrid molecules during the switch indicates that both M2 and R genes are expressed within each erythroid precursor cell. The developmental changes in erythrocyte pyruvate kinase are consistent with the role of this enzyme in the regulation of the oxygen-transport function of canine hemoglobin by 2,3-diphosphoglycerate in the postnatal period.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6626141     DOI: 10.1007/bf00498916

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  27 in total

1.  Postnatal regulation of oxygen delivery: hematologic parameters of postnatal dogs.

Authors:  P A Mueggler; J S Peterson; R D Koler; J Metcalfe; J A Black
Journal:  Am J Physiol       Date:  1979-07

2.  Multimolecular forms of pyruvate kinase. II. Purification of M 2 -type pyruvate kinase from Yoshida ascites hepatoma 130 cells and comparative studies on the enzymological and immunological properties of the three types of pyruvate kinases, L, M 1 , and M 2 .

Authors:  K Imamura; K Taniuchi; T Tanaka
Journal:  J Biochem       Date:  1972-10       Impact factor: 3.387

3.  Anomalous pyruvate kinase deficiency in the Basenji dog.

Authors:  R J Standerfer; J W Templeton; J A Black
Journal:  Am J Vet Res       Date:  1974-12       Impact factor: 1.156

4.  Electrophoretic and kinetic studies of mutant erythrocyte pyruvate kinases.

Authors:  K Nakashima; S Miwa; S Oda; T Tanaka; K Imamura
Journal:  Blood       Date:  1974-04       Impact factor: 22.113

5.  Postnatal changes in oxygen affinity and concentrations of 2,3-diphosphoglycerate in dog blood.

Authors:  D S Dhindsa; A S Hoversland; J W Templeton
Journal:  Biol Neonate       Date:  1972

6.  Absence of special fetal hemoglobin in beagle dogs.

Authors:  C N LeCrone
Journal:  Blood       Date:  1970-04       Impact factor: 22.113

7.  Different response to organic phosphates of human fetal and adult hemoglobins.

Authors:  I Tyuma; K Shimizu
Journal:  Arch Biochem Biophys       Date:  1969-01       Impact factor: 4.013

8.  Hereditary persistence of fetal erythrocyte pyruvate kinase in the Basenji dog.

Authors:  J A Black; M B Rittenberg; R J Standerfer; J S Peterson
Journal:  Prog Clin Biol Res       Date:  1978

9.  The genetic system of the L-type pyruvate kinase forms in man. Subunit structure, interrelation and kinetic characteristics of the pyruvate kinase enzymes from erythrocytes and liver.

Authors:  A Kahn; J Marie; H Garreau; E D Sprengers
Journal:  Biochim Biophys Acta       Date:  1978-03-14

10.  Hemolytic anemia due to pyruvate kinase deficiency: characterization of the enzymatic activity from eight patients.

Authors:  J A Black; M B Rittenberg; R H Bigley; R D Koler
Journal:  Am J Hum Genet       Date:  1979-05       Impact factor: 11.025

View more
  1 in total

1.  Modulation of Malaria Phenotypes by Pyruvate Kinase (PKLR) Variants in a Thai Population.

Authors:  Rebekah van Bruggen; Christian Gualtieri; Alexandra Iliescu; Chalisa Louicharoen Cheepsunthorn; Punchalee Mungkalasut; Jean-François Trape; David Modiano; Bienvenu Sodiomon Sirima; Pratap Singhasivanon; Mark Lathrop; Anavaj Sakuntabhai; Jean-François Bureau; Philippe Gros
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.